Biomarker Research

Featured research: Aptamer-based search for correlates of plasma and serum water T2

Metabolic syndrome is a cluster of abnormalities that increases the risk for type 2 diabetes and atherosclerosis. Plasma and serum water T2 from benchtop nuclear magnetic resonance relaxometry are early, global and practical biomarkers for metabolic syndrome and its underlying abnormalities. This study by Patel et al. used a modified aptamer (SOMAmer) library, enabling an unbiased search for new proteins correlated with water T2 and thus, metabolic health. The identification of new proteins associated with water T2 demonstrates the value of this approach to biomarker discovery.

Content type: Review
| 8 November 2018

Molecular landscape and targeted therapy of acute myeloid leukemia

Authors: Runxia Gu, Xue Yang and Hui Wei
Content type: Research
| 30 October 2018

Overexpression and cytoplasmic localization of caspase-6 is associated with lamin A degradation in set of ovarian cancers

Authors: Callinice D Capo-chichi, Kathy Q Cai and Xiang-Xi Xu
Content type: Research
| 30 October 2018

Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts

Authors: Chiara Agnoletto, Linda Minotti, Laura Brulle-Soumare, Lorenzo Pasquali, Marco Galasso, Fabio Corrà, Federica Baldassari, Jean-Gabriel Judde, Stefano Cairo and Stefano Volinia
Content type: Review
| 26 September 2018

SRSF2 mutations in myelodysplasia/myeloproliferative neoplasms

Authors: Amandeep Aujla, Katherine Linder, Chaitanya Iragavarapu, Michael Karass and Delong Liu
Content type: Research
| 17 September 2018

Aptamer-based search for correlates of plasma and serum water T₂: implications for early metabolic dysregulation and metabolic syndrome

Authors: Vipulkumar Patel, Alok K. Dwivedi, Sneha Deodhar, Ina Mishra and David P. Cistola

Most recent articles RSS

View all articles

Content type: Research
| 7 April 2016

The combinatorial approach of laser-captured microdissection and reverse transcription quantitative polymerase chain reaction accurately determines HER2 status in breast cancer

Authors: Elisabeth Hofmann, Rita Seeboeck, Nico Jacobi, Peter Obrist, Samuel Huter, Christian Klein, Kamil Oender, Christoph Wiesner, Harald Hundsberger and Andreas Eger
Content type: Review
| 1 April 2013

Metabolomic analyses for atherosclerosis, diabetes, and obesity

Authors: Fuyong Du, Anthony Virtue, Hong Wang and Xiao-Feng Yang
Content type: Review
| 7 January 2014

Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases

Authors: Jiyeon Yang, Lixiao Zhang, Caijia Yu, Xiao-Feng Yang and Hong Wang
Content type: Review
| 10 February 2014

CD 123 is a membrane biomarker and a therapeutic target in hematologic malignancies

Authors: Ugo Testa, Elvira Pelosi and Arthur Frankel
Content type: Review
| 5 February 2013

Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy

Authors: Kai Zhu, Zhi Dai and Jian Zhou

Most accessed articles RSS

View all articles

Editors-in-Chief

Chung-Tsen Hsueh, Loma Linda University, USA

Delong Liu, New York Medical College, USA

Aims and scope

Biomarker Research is an open access, peer-reviewed journal that encompasses all aspects of biomarker investigation. Biomarker Research aims to publish original discoveries, novel concepts, commentaries and reviews related to biomarker investigation from all biomedical disciplines.

The study of biomarkers has evolved rapidly in the advance of personalized medicine and individual health. The identification and validation of biomarkers in drug discovery/development and in disease diagnosis, treatment, prognosis, and prevention play an essential role in the genome era. With a quick turnaround time from submission to publication and online feedback from readers, Biomarker Research strives to provide fast dissemination of novel findings and new knowledge.

Featured research: Fibronectin protein expression in renal cell carcinoma in correlation with clinical stage of tumour

Biomarker Research

Featured research: Aptamer-based search for correlates of plasma and serum water T2

Articles

Molecular landscape and targeted therapy of acute myeloid leukemia

Overexpression and cytoplasmic localization of caspase-6 is associated with lamin A degradation in set of ovarian cancers

Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts

SRSF2 mutations in myelodysplasia/myeloproliferative neoplasms

Aptamer-based search for correlates of plasma and serum water T₂: implications for early metabolic dysregulation and metabolic syndrome

The combinatorial approach of laser-captured microdissection and reverse transcription quantitative polymerase chain reaction accurately determines HER2 status in breast cancer

Metabolomic analyses for atherosclerosis, diabetes, and obesity

Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases

CD 123 is a membrane biomarker and a therapeutic target in hematologic malignancies

Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy

Editors-in-Chief

Aims and scope

Featured research: Fibronectin protein expression in renal cell carcinoma in correlation with clinical stage of tumour

2017 Journal Metrics

Biomarker Research

Contact us